Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges Sevan DirmesropianJames G. WoodAnthony T. Newall Current Opinion 25 February 2016 Pages: 723 - 731
Economic Evaluation of Childhood Obesity Interventions: Reflections and Suggestions Emma Frew Leading Article 11 March 2016 Pages: 733 - 740
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective P. ThokalaE. L. SimpsonP. Harrison Review Article 18 February 2016 Pages: 741 - 750
Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension Shuyan GuHuimei HuHengjin Dong Systematic Review 07 March 2016 Pages: 751 - 770
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions Catrin O. PlumptonDaniel RobertsDyfrig A. Hughes Systematic Review 16 March 2016 Pages: 771 - 793
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial Lars OddershedeSimon WalkerFor the Protease Inhibitor monotherapy Versus Ongoing Triple therapy (PIVOT) Trial Team Original Research Article 10 March 2016 Pages: 795 - 804
The Impact of Different DCE-Based Approaches When Anchoring Utility Scores Richard NormanBrendan MulhernRosalie Viney Original Research Article 31 March 2016 Pages: 805 - 814
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria Jonathan GrahamDoreen McBrideAlan Brennan Original Research Article Open access 21 May 2016 Pages: 815 - 827